Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
biotech
clinical trials
gene therapy
life sciences
national
national blog main
national top stories
new york top stories
novartis
san francisco top stories
zolgensma
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
bristol-myers squibb
drug prices
eli lilly
genentech
glaxosmithkline
johnson & johnson
What
bio
roundup
drug
fda
new
news
america
approval
approved
atrophy
august
biogen
biogen’s
biopharmaceutical
biotech
busy
companies
continues
convo
convoluted
daily
days
decisions
democrats
devices
dreams
drugs
earlier
evrysdi
failures
friday
green
head
headaches
healthcare
holding
home
insurance
intended
ipo
Language
unset
Current search:
zolgensma
×
biogen
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More